Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: the UPSTREAM (Ultrasound in PSoriatic arthritis TREAtMent) prospective observational study protocol

Marco Canzoni, Matteo Piga, Alen Zabotti, Carlo Alberto Scirè, Greta Carrara, Ignazio Olivieri, Annamaria Iagnocco, Marco Canzoni, Matteo Piga, Alen Zabotti, Carlo Alberto Scirè, Greta Carrara, Ignazio Olivieri, Annamaria Iagnocco

Abstract

Introduction: Psoriatic arthritis (PsA) occurs in 10%-15% of people with psoriasis and accounts for 10%-20% of early arthritis clinics referral. Only a few prognostic factors of therapeutic response in patients with PsA have been identified. In the last years, the role of imaging has grown up and the European League Against Rheumatism recognised that ultrasound (US) has higher sensitivity than clinical examination to detect inflammatory disease activity. The aims of the Ultrasound in PSoriatic arthritis TREAtMent (UPSTREAM) study are to integrate clinic and US in order to inform whether US has provide an added prognostic value in PsA.

Methods and analysis: UPSTREAM is an observational prospective cohort study enrolling patients with PsA having clinically active joint disease and starting a new course of therapy. The primary objective is to evaluate the additional value of US over clinical examination in detecting patients achieving minimal disease activity after 6 months. Data will be obtained at baseline and at standard clinical follow-up visits. Patient's clinical assessment will be performed according to the core set proposed by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis-Outcome Measures in Rheumatology. Sonographic evaluations will be performed by expert sonographers in 42 joints, 36 tendons, 12 entheses and 2 bursae, according to a score that will be purposely developed for PsA by the US Study Group of the Italian Society for Rheumatology. The UPSTREAM study will identify clinical and US predictors of response to treatment in patients with PsA and active peripheral arthritis starting a new course of therapy.

Ethics and dissemination: Ethic approval for this study has been obtained from the institutional review board (IRB)/independent ethics committee (IEC) Comitato Etico Lazio 1 (Prot. N 198 02-02-2017) and then locally from the IRB/IEC of each participating centre. Results will be published in relevant scientific journals and be disseminated in international conferences. Fully anonymised data will be accessible from authors upon request.

Trial registration number: NCT03330769; Pre-results.

Keywords: rheumatology; treatment response; ultrasound.

Conflict of interest statement

Competing interests: None declared.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

References

    1. Coates LC, Cook R, Lee K-A, et al. . Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care Res 2010;62:970–6. 10.1002/acr.20162
    1. Gossec L, Smolen JS, Ramiro S, et al. . European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 2016;75:208337 10.1136/annrheumdis-2015-208337
    1. Eder L, Thavaneswaran A, Chandran V, et al. . Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Ann Rheum Dis 2015;74:813–7. 10.1136/annrheumdis-2013-204448
    1. Theander E, Husmark T, Alenius G-M, et al. . Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA). Ann Rheum Dis 2014;73:407–13. 10.1136/annrheumdis-2012-201972
    1. Saber TP, Ng CT, Renard G, et al. . Remission in psoriatic arthritis: is it possible and how can it be predicted? Arthritis Res Ther 2010;12:R94 10.1186/ar3021
    1. Glintborg B, Østergaard M, Krogh NS, et al. . Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor α inhibitor therapy: results from the danish nationwide DANBIO registry. Arthritis & Rheumatism 2013;65:1213–23. 10.1002/art.37876
    1. Coates LC, Moverley AR, McParland L, et al. . Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. The Lancet 2015;386:2489–98. 10.1016/S0140-6736(15)00347-5
    1. Orbai A-M, de Wit M, Mease PJ, et al. . Updating the Psoriatic Arthritis (PsA) core domain set: a report from the PsA workshop at OMERACT 2016. J Rheumatol 2017;44:1522–8. 10.3899/jrheum.160904
    1. Cauli A, Piga M. The difficult task of assessing psoriatic arthritis. J Rheumatol 2015;42:2219–20. 10.3899/jrheum.151209
    1. Colebatch AN, Edwards CJ, Østergaard M, et al. . EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 2013;72:804–14. 10.1136/annrheumdis-2012-203158
    1. Mandl P, Navarro-Compán V, Terslev L, et al. . EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 2015;74:1327–39. 10.1136/annrheumdis-2014-206971
    1. Zabotti A, Bandinelli F, Batticciotto A, et al. . Musculoskeletal ultrasonography for psoriatic arthritis and psoriasis patients: a systematic literature review. Rheumatology 2017;56:1518–32. 10.1093/rheumatology/kex179
    1. Gutierrez M, Di Geso L, Salaffi F, et al. . Development of a preliminary US power Doppler composite score for monitoring treatment in PsA. Rheumatology 2012;51:1261–8. 10.1093/rheumatology/kes014
    1. Ficjan A, Husic R, Gretler J, et al. . Ultrasound composite scores for the assessment of inflammatory and structural pathologies in Psoriatic Arthritis (PsASon-Score). Arthritis Res Ther 2014;16:476 10.1186/s13075-014-0476-2
    1. Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 2010;69:48–53. 10.1136/ard.2008.102053
    1. Schoels MM, Aletaha D, Alasti F, et al. . Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis 2016;75:869 10.1136/annrheumdis-2015-eular.6515
    1. Fries JF, Spitz P, Kraines RG, et al. . Measurement of patient outcome in arthritis. Arthritis & Rheumatism 1980;23:137–45. 10.1002/art.1780230202
    1. Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55–78. 10.1016/0049-0172(73)90035-8
    1. Lubrano E, Cantini F, Costanzo A, et al. . Measuring psoriatic disease in clinical practice. An expert opinion position paper. Autoimmun Rev 2015;14:864–74. 10.1016/j.autrev.2015.05.010
    1. Labitigan M, Bahče-Altuntas A, Kremer JM, et al. . Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res 2014;66:600–7. 10.1002/acr.22185
    1. Gladman DD. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2008. J Rheumatol 2010;37:446–7. 10.3899/jrheum.090954
    1. Gladman DD, Mease PJ, Strand V, et al. . Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007;34:1167–70.
    1. Mease PJ. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res 2011;63(Suppl 11):S64–85. 10.1002/acr.20577
    1. Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: Assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis & Rheumatism 2008;59:686–91. 10.1002/art.23568
    1. Garrett S, Jenkinson T, Kennedy LG, et al. . A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286–91.
    1. Ashcroft DM, Wan Po AL, Williams HC, et al. . Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 1999;141:185–91. 10.1046/j.1365-2133.1999.02963.x
    1. Gossec L, de Wit M, Kiltz U, et al. . A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis 2014;73:1012–9. 10.1136/annrheumdis-2014-205207
    1. Di Carlo M, Becciolini A, Lato V, et al. . The 12-item psoriatic arthritis impact of disease questionnaire: construct validity, reliability, and interpretability in a clinical setting. J Rheumatol 2017;44:279–85. 10.3899/jrheum.160924
    1. Zabotti A, Piga M, Canzoni M, et al. . Ultrasonography in psoriatic arthritis: which sites should we scan? Ann Rheum Dis 2018:annrheumdis-2018-213025 10.1136/annrheumdis-2018-213025
    1. Wakefield RJ, Emery P, Veale D. Ultrasonography and psoriatic arthritis. J Rheumatol 2000;27:1564–5.
    1. Scheel AK, Hermann K-GA, Kahler E, et al. . A novel ultrasonographic synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritis. Arthritis & Rheumatism 2005;52:733–43. 10.1002/art.20939
    1. Szkudlarek M, Court-Payen M, Jacobsen S, et al. . Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis & Rheumatism 2003;48:955–62. 10.1002/art.10877
    1. D’Agostino M-A, Boers M, Wakefield RJ, et al. . Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE study. RMD Open 2016;2:e000237 10.1136/rmdopen-2015-000237
    1. Wakefield RJ, Balint PV, Szkudlarek M, et al. . Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005;32:2485–7.
    1. Terslev L, Naredo E, Iagnocco A, et al. . Defining enthesitis in spondyloarthritis by ultrasound: results of a delphi process and of a reliability reading exercise. Arthritis Care Res 2014;66:741–8. 10.1002/acr.22191
    1. Hammer HB, Iagnocco A, Mathiessen A, et al. . Global ultrasound assessment of structural lesions in osteoarthritis: a reliability study by the OMERACT ultrasonography group on scoring cartilage and osteophytes in finger joints. Ann Rheum Dis 2016;75:402–7. 10.1136/annrheumdis-2014-206289
    1. Gutierrez M, Filippucci E, Salaffi F, et al. . Differential diagnosis between rheumatoid arthritis and psoriatic arthritis: the value of ultrasound findings at metacarpophalangeal joints level. Ann Rheum Dis 2011;70:1111–4. 10.1136/ard.2010.147272
    1. Zabotti A, Salvin S, Quartuccio L, et al. . Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands. Clin Exp Rheumatol 2016;34:459–65.
    1. Hirji Z, Hunjun J, Choudur H. Imaging of the bursae. J Clin Imaging Sci 2011;1:22 10.4103/2156-7514.80374
    1. Naredo E, D’Agostino MA, Wakefield RJ, et al. . Reliability of a consensus-based ultrasound score for tenosynovitis in rheumatoid arthritis. Ann Rheum Dis 2013;72:1328–34. 10.1136/annrheumdis-2012-202092
    1. Bruyn GAW, Hanova P, Iagnocco A, et al. . Ultrasound definition of tendon damage in patients with rheumatoid arthritis. Results of a OMERACT consensus-based ultrasound score focussing on the diagnostic reliability. Ann Rheum Dis 2014;73:1929–34. 10.1136/annrheumdis-2013-203596
    1. van der Heijde DMFM. Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. Baillière’s Clinical Rheumatology 1996;10:435–53. 10.1016/S0950-3579(96)80043-4
    1. Zabotti A, Idolazzi L, Batticciotto A, et al. . Enthesitis of the hands in psoriatic arthritis: an ultrasonographic perspective. Med Ultrason 2017;19:438 10.11152/mu-1172

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다